JNK1 as a Molecular Target To Limit Cellular Mortality under Hypoxia
- 29 June 2006
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 3 (4), 424-430
- https://doi.org/10.1021/mp060014x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Remediation of Cellular Hypoxic Damage by Pharmacological AgentsCurrent Pharmaceutical Design, 2005
- Tumor-specific targeting of an anticancer drug delivery system by LHRH peptideProceedings of the National Academy of Sciences, 2005
- MAPK kinase kinases (MKKKs) as a target class for small-molecule inhibition to modulate signaling networks and gene expressionCurrent Opinion in Chemical Biology, 2005
- Review:Hypoxia-Inducible Factor-1 (HIF-1): A Novel Transcription Factor in Immune ReactionsJournal of Interferon & Cytokine Research, 2005
- Enhancement of the Efficacy of Chemotherapy for Lung Cancer by Simultaneous Suppression of Multidrug Resistance and Antiapoptotic Cellular DefenseCancer Research, 2004
- Rat liver ischemia–reperfusion-induced apoptosis and necrosis are decreased by FK506 pretreatmentEuropean Journal of Pharmacology, 2003
- Simultaneous modulation of multidrug resistance and antiapoptotic cellular defense by MDR1 and BCL-2 targeted antisense oligonucleotides enhances the anticancer efficacy of doxorubicin.Pharmaceutical Research, 2003
- Selected Contribution: Lung hypoxia: antioxidant and antiapoptotic effects of liposomal α-tocopherolJournal of Applied Physiology, 2002
- The Regulation of AP-1 Activity by Mitogen-activated Protein KinasesJournal of Biological Chemistry, 1995
- JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domainCell, 1994